Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Blue Jet Healthcare Limited (BLUEJET.NS)

Compare
760.80
+13.45
+(1.80%)
At close: 3:30:00 PM GMT+5:30
Loading Chart for BLUEJET.NS
  • Previous Close 747.35
  • Open 747.35
  • Bid 758.00 x --
  • Ask 760.70 x --
  • Day's Range 722.00 - 771.00
  • 52 Week Range 347.60 - 968.30
  • Volume 359,048
  • Avg. Volume 558,846
  • Market Cap (intraday) 132.194B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 56.23
  • EPS (TTM) 13.53
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (0.13%)
  • Ex-Dividend Date Sep 18, 2024
  • 1y Target Est 854.00

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

www.bluejethealthcare.com

447

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BLUEJET.NS

View More

Performance Overview: BLUEJET.NS

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BLUEJET.NS
34.73%
S&P BSE SENSEX (^BSESN)
0.53%

1-Year Return

BLUEJET.NS
95.28%
S&P BSE SENSEX (^BSESN)
7.69%

3-Year Return

BLUEJET.NS
100.21%
S&P BSE SENSEX (^BSESN)
34.65%

5-Year Return

BLUEJET.NS
100.21%
S&P BSE SENSEX (^BSESN)
148.67%

Compare To: BLUEJET.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BLUEJET.NS

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    129.86B

  • Enterprise Value

    126.12B

  • Trailing P/E

    55.20

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.85

  • Price/Book (mrq)

    14.03

  • Enterprise Value/Revenue

    14.46

  • Enterprise Value/EBITDA

    37.80

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.88%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.73B

  • Net Income Avi to Common (ttm)

    2.35B

  • Diluted EPS (ttm)

    13.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.64B

  • Total Debt/Equity (mrq)

    0.12%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BLUEJET.NS

View More

Company Insights: BLUEJET.NS

Research Reports: BLUEJET.NS

View More

People Also Watch